Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Costantini

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 16, 2008
Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexateDanny L Costantini, Katherine Bateman, Kristin McLarty, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|February 12, 1998
[Hepatitis C virus and mixed cryoglobulinemia in dialysis]P Colombo, A Cascina, C Monzeglio, et al.
Parkinsonism & Related Disorders|May 2, 2001
Cell implantation therapies for Parkinson's disease using neural stem, transgenic or xenogeneic donor cellsO Isacson, L Costantini, J M. Schumacher, et al.
Nephron|January 1, 1992
Prevalence of hepatitis C infection in a hemodialysis unitP Colombo, O Filiberti, M Porcu, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 1, 1991
[Levels of tumor necrosis factor and interleukin 1 in uremia and in hemodialysis]C Peona, A Fortina, P Colombo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Antitumor effects and normal-tissue toxicity of 111In-nuclear localization sequence-trastuzumab in athymic mice bearing HER-positive human breast cancer xenograftsDanny L Costantini, Kristin McLarty, Helen Lee, et al.
European Journal of Applied Physiology|June 5, 2020
Analysis of changes in cardiac circadian rhythms of RR and QT induced by a 60-day head-down bed rest with and without nutritional countermeasureS Solbiati, F Landreani, M Turcato, et al.
International Journal of Molecular Imaging|June 18, 2016
A Pilot Study of 18F-FLT PET/CT in Pediatric LymphomaDanny L Costantini, Reza Vali, Susan McQuattie, et al.
The Science of the Total Environment|December 22, 2019
Isotopic biomonitoring of N pollution in rivers embedded in complex human landscapesE Calizza, F Favero, D Rossi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2009
Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenograftsKristin McLarty, Bart Cornelissen, Zhongli Cai, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 16, 2008
Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexateDanny L Costantini, Katherine Bateman, Kristin McLarty, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|February 12, 1998
[Hepatitis C virus and mixed cryoglobulinemia in dialysis]P Colombo, A Cascina, C Monzeglio, et al.
Parkinsonism & Related Disorders|May 2, 2001
Cell implantation therapies for Parkinson's disease using neural stem, transgenic or xenogeneic donor cellsO Isacson, L Costantini, J M. Schumacher, et al.
Nephron|January 1, 1992
Prevalence of hepatitis C infection in a hemodialysis unitP Colombo, O Filiberti, M Porcu, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 1, 1991
[Levels of tumor necrosis factor and interleukin 1 in uremia and in hemodialysis]C Peona, A Fortina, P Colombo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Antitumor effects and normal-tissue toxicity of 111In-nuclear localization sequence-trastuzumab in athymic mice bearing HER-positive human breast cancer xenograftsDanny L Costantini, Kristin McLarty, Helen Lee, et al.
European Journal of Applied Physiology|June 5, 2020
Analysis of changes in cardiac circadian rhythms of RR and QT induced by a 60-day head-down bed rest with and without nutritional countermeasureS Solbiati, F Landreani, M Turcato, et al.
International Journal of Molecular Imaging|June 18, 2016
A Pilot Study of 18F-FLT PET/CT in Pediatric LymphomaDanny L Costantini, Reza Vali, Susan McQuattie, et al.
The Science of the Total Environment|December 22, 2019
Isotopic biomonitoring of N pollution in rivers embedded in complex human landscapesE Calizza, F Favero, D Rossi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2009
Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenograftsKristin McLarty, Bart Cornelissen, Zhongli Cai, et al.
Pageof 4